Skip to main content

Pitavastatin

NDC 0480-3632 · Teva Pharmaceuticals, Inc.

Generic namepitavastatin calcium
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)PITAVASTATIN CALCIUM
Strength2.09 mg/1
Pharmacologic classHMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
Marketing categoryANDA

Packages

0480-3632-98 — 90 TABLET, FILM COATED in 1 BOTTLE (0480-3632-98)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0378-5055 — pitavastatin, 0378-5056 — pitavastatin, 0378-5057 — pitavastatin, 0480-3631 — pitavastatin calcium, 0480-3633 — pitavastatin calcium, 0832-6048 — Pitavastatin Calcium, 0832-6049 — Pitavastatin Calcium, 0832-6050 — Pitavastatin Calcium, 31722-875 — pitavastatin calcium, 31722-876 — pitavastatin calcium, 31722-877 — pitavastatin calcium, 42291-905 — pitavastatin calcium, 42291-906 — pitavastatin calcium, 42291-907 — pitavastatin calcium, 51407-956 — Pitavastatin Calcium, 51407-957 — Pitavastatin Calcium, 51407-958 — Pitavastatin Calcium, 65162-029 — Pitavastatin, 65162-030 — Pitavastatin, 65162-031 — Pitavastatin, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels